Everolimus-based therapy in patients with hormone receptor-positive, HER2- advanced breast cancer: Management considerations

Lucia Del Mastro, Marina Cazzaniga, Paolo Solidoro, Daniele Generali, Giulia Bianchi, Franco Testore, Sabino De Placido

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2251-2254
Number of pages4
JournalFuture Oncology
Issue number16
Publication statusPublished - Aug 1 2015


  • adverse events
  • breast cancer
  • compliance
  • dosing
  • everolimus
  • management
  • multidisciplinary follow-up
  • toxicity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this